Κυριακή 13 Μαΐου 2018

Transsplenic splenoportography and portal venous interventions in pediatric patients

Abstract

Background

Data regarding transsplenic portal venous access for diagnostic imaging and endovascular intervention in children are limited, possibly due to concerns regarding high bleeding risks and resultant underutilization.

Objective

To investigate the safety and utility of transsplenic splenoportography and portal venous interventions in children.

Materials and methods

A retrospective review was performed of all pediatric patients undergoing percutaneous transsplenic portal venous access and intervention at two large tertiary pediatric institutions between January 2012 and April 2017 was performed. Parameters assessed included procedural indications, procedural and relevant prior imaging, technical details of the procedures, laboratory values and clinical follow-up.

Results

Transsplenic portal venous access was achieved in all patients. Diagnostic transsplenic splenoportography was performed in 22 patients and was 100% successful at providing the desired anatomical and functional information. Four transsplenic portal venous interventions were performed with 100% success: meso-Rex shunt angioplasty, snare targeted transjugular intrahepatic portosystemic shunt (TIPS) creation through cavernous transformation, pharmacomechanical thrombectomy for acute thrombosis, and transplant portal vein angioplasty. Intraperitoneal bleeding occurred in 2/26 (7.7%) and one case required transfusion (3.8%). No cases of hemorrhage were observed when transsplenic access size was 4 Fr or smaller.

Conclusion

Transsplenic splenoportography in children is safe and effective when noninvasive imaging methods have yielded incomplete information. Additionally, a transsplenic approach has advantages for complex portal interventions. Bleeding risks are proportional to tract access size and may be mitigated by tract embolization.



https://ift.tt/2GbX38F

Transsplenic splenoportography and portal venous interventions in pediatric patients

Abstract

Background

Data regarding transsplenic portal venous access for diagnostic imaging and endovascular intervention in children are limited, possibly due to concerns regarding high bleeding risks and resultant underutilization.

Objective

To investigate the safety and utility of transsplenic splenoportography and portal venous interventions in children.

Materials and methods

A retrospective review was performed of all pediatric patients undergoing percutaneous transsplenic portal venous access and intervention at two large tertiary pediatric institutions between January 2012 and April 2017 was performed. Parameters assessed included procedural indications, procedural and relevant prior imaging, technical details of the procedures, laboratory values and clinical follow-up.

Results

Transsplenic portal venous access was achieved in all patients. Diagnostic transsplenic splenoportography was performed in 22 patients and was 100% successful at providing the desired anatomical and functional information. Four transsplenic portal venous interventions were performed with 100% success: meso-Rex shunt angioplasty, snare targeted transjugular intrahepatic portosystemic shunt (TIPS) creation through cavernous transformation, pharmacomechanical thrombectomy for acute thrombosis, and transplant portal vein angioplasty. Intraperitoneal bleeding occurred in 2/26 (7.7%) and one case required transfusion (3.8%). No cases of hemorrhage were observed when transsplenic access size was 4 Fr or smaller.

Conclusion

Transsplenic splenoportography in children is safe and effective when noninvasive imaging methods have yielded incomplete information. Additionally, a transsplenic approach has advantages for complex portal interventions. Bleeding risks are proportional to tract access size and may be mitigated by tract embolization.



from Cancer via ola Kala on Inoreader https://ift.tt/2GbX38F
via IFTTT

A Case of Medialized Lateral Maxillary Sinus Wall: A Pillar of Support

The number of maxillofacial trauma (MFT) cases attended in the Emergency Department is progressively increasing in trend, owing to the rising statistics of motor-vehicle accidents (MVAs) and urban assaults in addition to occupational-related injuries. Prompt and thorough assessment is important for accurate diagnosis and paramount treatment plans. We will be discussing a case of unusual presentation of an orbital floor fracture post-MVA which was treated conservatively based on the clinical assessments during follow-ups, supported by radiological findings. We will also briefly discuss the different radiological modalities available in assessing MFT and late presentation of enophthalmos.

https://ift.tt/2jRE6PO

Σάββατο 12 Μαΐου 2018

The new world of biosimilars in oncology: Translation of data to the clinic

elsevier-non-solus.png

Publication date: June 2018
Source:European Journal of Cancer, Volume 96
Author(s): Hope S. Rugo, Javier Cortes




from Cancer via ola Kala on Inoreader https://ift.tt/2KTXs30
via IFTTT

Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure

elsevier-non-solus.png

Publication date: June 2018
Source:European Journal of Cancer, Volume 96
Author(s): Andrea Necchi, Daniele Raggi, Patrizia Giannatempo, Alessandra Alessi, Gianluca Serafini, Maurizio Colecchia, Siraj M. Ali, Jon H. Chung




from Cancer via ola Kala on Inoreader https://ift.tt/2rCJ2vv
via IFTTT

Letter comments on EJC published paper: ‘No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study’

alertIcon.gif

Publication date: Available online 11 May 2018
Source:European Journal of Cancer
Author(s): Per Henrik Zahl




from Cancer via ola Kala on Inoreader https://ift.tt/2KWxfko
via IFTTT

Re: No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer Study

alertIcon.gif

Publication date: Available online 11 May 2018
Source:European Journal of Cancer
Author(s): Eiliv Lund, Aurelie Nakamura, Jean-Christophe Thalabard




from Cancer via ola Kala on Inoreader https://ift.tt/2rEfPQY
via IFTTT